General
Preferred name
AMOXAPINE
Synonyms
CL-67772 ()
CL 67772,Asendin ()
Amoxapina ()
CL 67772 ()
CL-67,772 ()
Asendis ()
Defanyl ()
NSC-759559 ()
Asendin ()
CL 67,772 ()
P&D ID
PD000076
CAS
14028-44-5
Tags
available
drug
Approved by
FDA
First approval
1980
Drug indication
Major depressive disorder
Antidepressant
Drug Status
approved
Max Phase
4.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Amoxapine is a dibenzoxazepine-derivative tricyclic antidepressant.
(GtoPdb)
DESCRIPTION
Tricyclic antidepressant; inhibits neuronal uptake of norepinephrine
(LOPAC library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
0
Organisms
4
Compound Sets
30
Axon Medchem Screening Library
Cayman Chemical Bioactives
CeMM library of unique drugs (CLOUD)
ChEMBL Approved Drugs
ChEMBL Drugs
CZ-OPENSCREEN Bioactive Library
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
Enamine BioReference Compounds
Guide to Pharmacology
Ki Database
LOPAC library
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
NIH Clinical Collections (NCC)
Novartis Chemogenetic Library (NIBR MoA Box)
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
ZINC Tool Compounds
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
35
Molecular Weight
313.1
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
1
Rotatable Bonds
0
Ring Count
4
Aromatic Ring Count
2
cLogP
3.43
TPSA
36.86
Fraction CSP3
0.24
Chiral centers
0.0
Largest ring
7.0
QED
0.81
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Selectivity
Uptake
MOA
norepinephrine transporter inhibitor
GlyT inhibitor
5-HT2A Antagonists
5-HT Reuptake Inhibitors
Norepinephrine Reuptake Inhibitors
norepinephrine reputake inhibitor
Target
Dopamine Receptor
Serotonin Transporter
Norepinephrine transporter
GlyT1b
GlyT2a
ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HRH1, HRH4, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR3A, HTR6, HTR7, SLC6A2, SLC6A3, SLC6A4
Tricyclic antidepressant
Bacterial
Amino acid transporter,GlyT
Pathway
Neuroscience
Anti-infection
Autophagy
Member status
member
Indication
depression
Therapeutic Class
Antidepressants
Source data